Thank you ❤️

NK 👸!!

One of the kindest, smartest and generous humans I know! Congrats Pat!!!

Thanks to Haeseong Park, MD, MPH, of Dana-Farber for stopping by for an interview on her AACR presentation on a phase 1 trial of epacadostat plus preoperative chemoradiation in locally advanced rectal cancer #AACR2024

👏 Attn: We have a new AACR President Patricia M. LoRusso - clinician scientist extraordinaire, Dr. PatLoRusso! Dr. LoRusso outlined some of her priorities today;
🎯 ⬆️ outreach to patients
🎯 ⬆️ recruitment/retention of underrepresented researchers
🎯 @AACR Center for Cancer Clinical Trials
#AACR24

Fingers crossed! It will be the first cellular therapy approval in solid tumor!@MDAndersonNews Adaptimmune

The Legend-Lee Ellis! #AACR24 @MDAndersonNews

What an amazing session with KRAS 🤴 Kevan Shokat and the Revolutionary team from Revolution medicine-Wei Lin,Elena Kolton and Sandra Gabelli from Merck #AACR24 MD Anderson Cancer Center

We call Dr Rodon the Oncology Philosopher! His thoughts on new oncology therapeutics goes deep!!! MD Anderson Cancer Center

DDR 🤴!!!

Timothy Yap, PhD, of MD Anderson Cancer Center presents first-in-human phase 1/2a trial of first-in-class saruparib monotherapy. The new generation PARP inhibitor demonstrated a
promising ORR and PFS in patients with certain HRR-deficient #breastcancer . #AACR24

DDR 🤴!!

GFH375 (VS-7375): An oral, selective #KRAS G12D (ON/OFF) inhibitor with potent anti-tumor efficacy.
#AACR24 Anirban Maitra LARVOL Daniel Gerlach Darryl B McConnell Vivek Subbiah, MD David S. Hong MD soria Jay Bradner, M.D. Stephen V Liu, MD Bruna Pellini, MD Filip Janku Scott Kopetz Ziyang Zhang Simanshu Dhirendra

$BMY #AACR24 Krazati + Erbitux in CRC cohort of Krystal-1 via Scott Kopetz

Daniel welcome to the MDACC community and join us the RAStafarians who are a group of investigators studying and exploring RAS targeted therapy!

Out in nature concurrent with #AACR24
Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer
KenOliveLab Ben Stanger Der Lab at UNC
nature.com/articles/s4158…
nature.com/articles/s4158…

Happening now! Clinical Trials Plenary Session-Advances in Targeted Therapy #AACR24 with the DDR 🤴Tim Yap and the CRC 🤴 Scott Kopetz and the phase 1 🤴-the Alex Adjei!

Waun Ki Hong Award for Outstanding Achievement in Translational & Clinical Cancer Research bestowed to Scott Kopetz
The legacy of Dr Hong in cancer care and research is partially grasped by the caliber of many clinician scientists that he mentored Dr. Fadlo Khuri Roy Herbst…

Honored to have chaired the Tumor Targeted Immune cell engaged session at #AACR24 with my cochair Dr Shree from OHSU Knight Cancer Institute !

The man the myth! My brother from another mother-the Scott Kopetz ! So proud to see him with the Waun Ki Hong AACR award! Waun Ki would be proud MD Anderson Cancer Center